• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

专家意见:探索前列腺癌患者应该了解的术后放疗知识。

Opinions from the experts: exploring what prostate cancer patients should know about post-operative radiotherapy.

作者信息

D'Alimonte Laura, Koo Kaitlin, Chen Emily, Feldman-Stewart Deb, Court Arlene, Fitch Margaret, Di Prospero Lisa, Maamoun John, Kiss Alex, Szumacher Ewa

机构信息

Department of Radiation Therapy, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.

出版信息

J Cancer Educ. 2013 Sep;28(3):509-15. doi: 10.1007/s13187-013-0494-9.

DOI:10.1007/s13187-013-0494-9
PMID:23793963
Abstract

The present study investigated health professionals' opinions about important questions that should be discussed with patients who may require post-prostatectomy radiotherapy. A 74-question survey was conducted among radiation oncologists, urologists, nurses, and radiation therapists involved in the care of prostate cancer patients. Survey questions covered six domains: understanding my situation and prostate cancer diagnosis, making a decision, radiotherapy: procedures involved, potential benefits, side effects, and my support network during radiation treatment. Respondents rated the importance of addressing these questions as either essential, important, no opinion, or avoid with a hypothetical post-prostatectomy case. The majority of questions were rated as either essential or important. There was disagreement between professions on essential questions, mostly between nurses and urologists in the side-effects domain. There was agreement between all professions regarding which questions should be avoided.

摘要

本研究调查了医疗保健专业人员对于与可能需要前列腺切除术后放疗的患者讨论的重要问题的看法。对参与前列腺癌患者护理的放射肿瘤学家、泌尿科医生、护士和放射治疗师进行了一项包含74个问题的调查。调查问题涵盖六个领域:了解我的病情和前列腺癌诊断、做出决定、放疗:涉及的程序、潜在益处、副作用以及放疗期间我的支持网络。受访者针对一个假设的前列腺切除术后病例,将解决这些问题的重要性评为必不可少、重要、无意见或应避免。大多数问题被评为必不可少或重要。不同专业在必不可少的问题上存在分歧,主要是在副作用领域的护士和泌尿科医生之间。在应避免哪些问题上,所有专业达成了一致。

相似文献

1
Opinions from the experts: exploring what prostate cancer patients should know about post-operative radiotherapy.专家意见:探索前列腺癌患者应该了解的术后放疗知识。
J Cancer Educ. 2013 Sep;28(3):509-15. doi: 10.1007/s13187-013-0494-9.
2
What prostate cancer patients should know: variation in professionals' opinions.前列腺癌患者应该了解的内容:专业人士观点的差异。
Radiother Oncol. 1998 Nov;49(2):111-23. doi: 10.1016/s0167-8140(98)00091-7.
3
Knowledge, attitudes and beliefs towards management of men with locally advanced prostate cancer following radical prostatectomy: an Australian survey of urologists.对根治性前列腺切除术后局部晚期前列腺癌男性患者管理的知识、态度和信念:澳大利亚泌尿外科医生调查
BJU Int. 2016 Apr;117 Suppl 4:35-44. doi: 10.1111/bju.13037.
4
Patterns of Care Related to Post-Operative Radiotherapy for Patients with Prostate Cancer among Canadian Radiation Oncologists and Urologists.加拿大放射肿瘤学家和泌尿科医生中与前列腺癌患者术后放疗相关的护理模式
J Cancer Educ. 2018 Dec;33(6):1195-1200. doi: 10.1007/s13187-017-1230-7.
5
Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey.泌尿外科医生和放射肿瘤学家在局限性前列腺癌管理方面的实践模式差异:一项横断面调查。
World J Urol. 2015 Nov;33(11):1741-7. doi: 10.1007/s00345-015-1543-2. Epub 2015 Mar 31.
6
Does Specialty Bias Trump Evidence in the Management of High-risk Prostate Cancer?在高危前列腺癌的治疗中,专科偏见会胜过证据吗?
Am J Clin Oncol. 2018 Jun;41(6):549-557. doi: 10.1097/COC.0000000000000323.
7
Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.泌尿外科医生和放射肿瘤学家对临床局限性前列腺癌治疗建议的比较。
JAMA. 2000 Jun 28;283(24):3217-22. doi: 10.1001/jama.283.24.3217.
8
Urologists' referral and radiation oncologists' treatment patterns regarding high-risk prostate cancer patients receiving radiotherapy within 6 months after radical prostatectomy: A prospective cohort analysis.泌尿外科医生的转诊及放射肿瘤学家对前列腺癌根治术后6个月内接受放疗的高危前列腺癌患者的治疗模式:一项前瞻性队列分析。
J Med Imaging Radiat Oncol. 2020 Feb;64(1):134-143. doi: 10.1111/1754-9485.12979. Epub 2019 Dec 2.
9
The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: a survey of practice patterns of urologists and radiation oncologists in the United States.雄激素剥夺疗法在根治性放射治疗后出现生化或局部复发患者中的作用:美国泌尿外科医生和放射肿瘤学家的实践模式调查
Urology. 2001 Aug;58(2 Suppl 1):65-70. doi: 10.1016/s0090-4295(01)01244-4.
10
Information priorities of Italian early-stage prostate cancer patients and of their health-care professionals.意大利早期前列腺癌患者及其医护人员的信息优先级
Patient Educ Couns. 2005 Feb;56(2):174-81. doi: 10.1016/j.pec.2004.02.006.

本文引用的文献

1
International variation in prostate cancer incidence and mortality rates.前列腺癌发病率和死亡率的国际差异。
Eur Urol. 2012 Jun;61(6):1079-92. doi: 10.1016/j.eururo.2012.02.054. Epub 2012 Mar 8.
2
Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy.前列腺切除术后辅助和挽救性放疗的医师信念和实践。
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e233-8. doi: 10.1016/j.ijrobp.2011.04.003. Epub 2011 May 24.
3
Salvage or adjuvant radiation therapy: counseling patients on the benefits.
挽救性或辅助性放射治疗:向患者说明获益。
J Natl Compr Canc Netw. 2010 Feb;8(2):228-37. doi: 10.6004/jnccn.2010.0015.
4
Patient decision aids for prostate cancer treatment: a systematic review of the literature.前列腺癌治疗的患者决策辅助工具:文献系统综述
CA Cancer J Clin. 2009 Nov-Dec;59(6):379-90. doi: 10.3322/caac.20039. Epub 2009 Oct 19.
5
Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.前列腺癌根治术后 III 期辅助放疗与单纯前列腺癌根治术治疗术后前列腺特异性抗原检测不到的 pT3 前列腺癌的比较:ARO 96-02/AUO AP 09/95
J Clin Oncol. 2009 Jun 20;27(18):2924-30. doi: 10.1200/JCO.2008.18.9563. Epub 2009 May 11.
6
Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.病理T3N0M0前列腺癌的辅助放疗可显著降低转移风险并提高生存率:一项随机临床试验的长期随访
J Urol. 2009 Mar;181(3):956-62. doi: 10.1016/j.juro.2008.11.032. Epub 2009 Jan 23.
7
Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy.前列腺癌根治术后生化复发的男性患者接受挽救性放疗与观察后的前列腺癌特异性生存率。
JAMA. 2008 Jun 18;299(23):2760-9. doi: 10.1001/jama.299.23.2760.
8
Doctors' and patients' preferences for participation and treatment in curative prostate cancer radiotherapy.医生和患者对根治性前列腺癌放疗中参与治疗的偏好。
J Clin Oncol. 2007 Jul 20;25(21):3096-100. doi: 10.1200/JCO.2006.07.4955.
9
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.预测前列腺癌根治术后复发性前列腺癌挽救性放射治疗的结果。
J Clin Oncol. 2007 May 20;25(15):2035-41. doi: 10.1200/JCO.2006.08.9607.
10
Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial.病理分期晚期前列腺癌的辅助放疗:一项随机临床试验。
JAMA. 2006 Nov 15;296(19):2329-35. doi: 10.1001/jama.296.19.2329.